期刊文献+

伊马替尼胶束的制备与体外克服肿瘤耐药性的研究 被引量:1

Preparation of Imatinib Micelles and Research on in Vitro Overcoming Tumor Drug Resistance
原文传递
导出
摘要 目的伊马替尼(imatinib,IMN)包埋于托可索仑(tocofersolan,TPGS)胶束中,以提高其水溶性,并对其理化性质进行表征,及与人源耐药细胞株MCF-7/ADR的作用效果。通过TPGS胶束运输IMN进入细胞,可克服肿瘤细胞的多药耐药性,提高抗肿瘤效果,为进一步体内药效研究提供基础。方法采用薄膜分散法制备IMN-TPGS胶束,对其粒径、电位、形态、载药量和包封率及体外释放行为进行表征,考察该胶束对MCF-7/ADR细胞的抗肿瘤效果。结果IMN-TPGS胶束平均粒径为(22.69±2.39)nm,表面呈电中性,外观圆整,载药量为(1.55±0.06)%,包封率为(63.49±2.42)%;具有较高的耐稀释性,血清稳定性和冻干-复溶稳定性;在体外释放72 h后,累积释放度近100%,释放速率缓慢;IMN-TPGS胶束对MCF-7/ADR的IC_(50)为12.27μmol·L^(-1),细胞毒性大,细胞内药物含量高,可诱导近半数细胞凋亡。结论IMN-TPGS胶束粒径均一,分散性良好,稳定性高,具有较强抗稀释性,有利于体液长循环,对耐药细胞株有明显的抗肿瘤效果,在一定程度上可以克服其多药耐药性。 OBJECTIVE To embed imatinib(IMN)into micelles based on tocofersolan(TPGS)matrix,charecterize the physical and chemical properties of IMN-TPGS micelles and improve the anti-tumor effect.METHODS The thin film dispersion method was used to prepare IMN-TPGS micelles,and their particle size distribution,surface potential,morphology,drug loading,encapsulation efficiency and in vitro release behavior were characterized.The in vitro anti-tumor effect of IMN-TPGS micelles was investigated on MCF-7/ADR cells.RESULTS The average particle size of IMN-TPGS micelles was(22.69±2.39)nm,the drug loading was(1.55±0.06)%,and the encapsulation efficiency was(63.49±2.42)%.IMN-TPGS micelles with neutral surface showed a nearly sphere appearance.There was no significant change in diameter and drug loading after dilution times.IMN-TPGS micelles could be stable in the serum solution for 24 h.There was no significant difference in its particle size and encapsulation efficiency before and after freeze-drying.The in vitro cumulative release of IMN from TPGS micelles was close to 100%after 72 hours with a slow rate.The IC_(50) of the IMN-loaded TPGS micelles was 12.27μmol·L^(-1) consistent with its significant cellular uptake in MCF-7/ADR cells.CONCLUSION IMN-TPGS micelles with uniform particle size,good dispersibility and high stability,showed strong anti-dilution properties,which were conducive to the long circulation in body fluids.IMN-TPGS micelles exhibit obvious anti-tumor effects on drug-resistant cell lines,which could overcome multidrug resistance to a certain extent.
作者 吕风梅 李北雪 周翔 何駸頔 随力 刘哲鹏 LÜ Feng-mei;LI Bei-xue;ZHOU Xiang;HE Qin-di;SUI Li;LIU Zhe-peng(University of Shanghai for Science and Technology,Shanghai 200093,China)
机构地区 上海理工大学
出处 《中国药学杂志》 CAS CSCD 北大核心 2022年第7期554-562,共9页 Chinese Pharmaceutical Journal
关键词 伊马替尼 胶束 托可索仑 多药耐药性 imatinib micelle tocofersolan multidrug resistance
  • 相关文献

参考文献3

二级参考文献38

  • 1Rebecca Siegel,Jiemin Ma,Zhaohui Zou,Ahmedin Jemal.Cancer statistics, 2014[J]. CA A Cancer Journal for Clinicians . 2014 (1)
  • 2Shweta Bansal.??Is imatinib still the best choice as first-line oral TKI(J)South Asian Journal of Cancer . 2014 (1)
  • 3Jean-Yves Blay,Piotr Rutkowski.??Adherence to imatinib therapy in patients with gastrointestinal stromal tumors(J)Cancer Treatment Reviews . 2014 (2)
  • 4Aaron Rosenberg,Paul Mathew.??Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor(J)Expert Opinion on Investigational Drugs . 2013 (6)
  • 5Bruno F. Fernandes,Sebastian Di Cesare,Rubens Neto Belfort,Shawn Maloney,Claudia Martins,Enzo Castiglione,Jordan Isenberg,Daniel Abourbih,Emilia Antecka,Miguel N. Burnier Jr..??Imatinib mesylate alters the expression of genes related to disease progression in an animal model of uveal melanoma(J)Analytical Cellular Pathology . 2011 (3)
  • 6Hiroshi Haeno,Franziska Michor.??The evolution of tumor metastases during clonal expansion(J)Journal of Theoretical Biology . 2009 (1)
  • 7Marion T. Weigel,Ivo Meinhold-Heerlein,Dirk O. Bauerschlag,Christian Schem,Maret Bauer,Walter Jonat,Nicolai Maass,Christoph Mundhenke.??Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR β signalling(J)Cancer Letters . 2008 (1)
  • 8Bo Keun Jee,Joo Yong Lee,Young Lim,Kweon Haeng Lee,Yang-Hyeok Jo.??Effect of KAI1/CD82 on the β1 integrin maturation in highly migratory carcinoma cells(J)Biochemical and Biophysical Research Communications . 2007 (3)
  • 9Bozdogan O,Yulug G,Vargel I,Cavusoglu T,Karabulut A,Karahan G,et al.Differential expression pattern of metastasis suppressor proteins in basal cell carcinoma. International Journal of Dermatology . 2015
  • 10Saad Zaghloul MA,Abadi AH,Abdelaziz AI.Functional evaluation of imatinib mesylate in hepatocellular carcinoma cells. Recent Pat Biomark . 2013

共引文献6

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部